Platelet–lymphocyte ratio is an independent prognostic factor in patients with ALK-positive non-small-cell lung cancer

Future Oncology Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2aWUtda
via IFTTT